DJ Khaled Credits Wegovy and Golf for 75-Pound Weight Loss

Key points

• Khaled lost 75 pounds, or 25% of his body weight, since starting Wegovy in late 2025.
• He walks 18 holes of golf up to six times a week, logging over 10,000 steps daily.
• A performance incident in October 2025, where he struggled to rise from his knees, served as the catalyst for change.
• Khaled is now a partner for Novo Nordisk, promoting the medication alongside his lifestyle changes.
• He aims to reach 200 pounds but reports increased energy and improved health metrics.

Background

This development follows a broader trend of public figures discussing GLP-1 medications for weight management. Earlier this month, our archive noted Khaled's initial disclosure of his weight loss journey. The current news expands on that with details regarding his commercial partnership with Novo Nordisk and specific lifestyle adjustments, such as his golf routine and dietary changes.

How outlets are covering it

TMZ and People emphasize the dramatic nature of the weight loss and the personal motivation behind it, citing Khaled's sons and a specific performance scare as key drivers. E! News highlights the combination of medication with lifestyle changes, noting Khaled's consistent golf routine and dietary adjustments. Fierce Pharma focuses on the commercial aspect, detailing the partnership between Khaled and Novo Nordisk and noting that Khaled's weight loss exceeds the average 15% reported in clinical trials for Wegovy. All sources agree on the 75-pound loss and the role of Wegovy, but differ in emphasis: TMZ and People focus on the personal story, while Fierce Pharma focuses on the marketing strategy and clinical comparison.

Why it matters

The story highlights the growing public acceptance and commercialization of GLP-1 medications for weight loss. Khaled's partnership with Novo Nordisk signals a shift in marketing strategies for these drugs, moving beyond clinical trials to real-world, celebrity-endorsed campaigns. It also underscores the intersection of health, lifestyle, and commercial interests in the wellness industry.

What to watch

Khaled plans to continue his current routine, aiming to reach 200 pounds. Novo Nordisk is expected to continue leveraging Khaled's campaign to re-energize its obesity franchise, particularly after a period of slowed growth due to competition from Eli Lilly and drug compounders. Khaled's upcoming charity golf tournament in Miami on December 3 may also serve as a platform to further promote his wellness message.